Hiv Drugs Patent

Indian pharma firms Aurobindo, Emcure, Hetero Labs, Laurus Labs, Lupin and Zydus Cadila are among the seven drug makers which have signed licensing pact with UN-backed Medicines Patent Pool (MPP) for producing HIV and hepatitis C drugs.

What serves as one of the biggest threats against people living with HIV AIDS is multinational drug companies, producing lifesaving drugs, pushing for patents so generic companies cannot produce them at much lower prices. However, in a much needed relief to Indian pharmaceutical companies as well as patients, India rejected a patent application fil...

This decision is also significant because of the message it sends to all companies waiting to patent their drugs, especially those meant to treat HIV/AIDS.

Indian pharma firms Aurobindo, Emcure, Hetero Labs, Laurus Labs, Lupin and Zydus Cadila are among the seven drug makers which have signed licensing pact with UN-backed Medicines Patent Pool (MPP) for producing HIV and hepatitis C drugs.

What serves as one of the biggest threats against people living with HIV AIDS is multinational drug companies, producing lifesaving drugs, pushing for patents so generic companies cannot produce them at much lower prices. However, in a much needed relief to Indian pharmaceutical companies as well as patients, India rejected a patent application fil...

This decision is also significant because of the message it sends to all companies waiting to patent their drugs, especially those meant to treat HIV/AIDS.